Total Payments
$21,948
2024 Payments
$1,425
Companies
36
Transactions
532
Medicare Patients
4,677
Medicare Billing
$392,506
Payment Breakdown by Category
Other$11,500 (52.4%)
Food & Beverage$10,368 (47.2%)
Education$79.96 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,500 | 8 | 52.4% |
| Food and Beverage | $10,368 | 517 | 47.2% |
| Education | $79.96 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $12,730 | 167 | $0 (2024) |
| ViiV Healthcare Company | $1,600 | 1 | $0 (2019) |
| JAZZ PHARMACEUTICALS INC. | $1,438 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,220 | 51 | $0 (2024) |
| Mylan Specialty L.P. | $966.09 | 60 | $0 (2024) |
| Axsome Therapeutics, Inc. | $642.91 | 20 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $626.66 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $371.77 | 20 | $0 (2022) |
| Grifols USA, LLC | $332.92 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $231.01 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,425 | 61 | Axsome Therapeutics, Inc. ($254.29) |
| 2023 | $1,784 | 83 | Axsome Therapeutics, Inc. ($388.62) |
| 2022 | $1,275 | 67 | GlaxoSmithKline, LLC. ($365.63) |
| 2021 | $1,266 | 72 | GlaxoSmithKline, LLC. ($370.38) |
| 2020 | $3,324 | 62 | GlaxoSmithKline, LLC. ($2,341) |
| 2019 | $10,586 | 65 | GlaxoSmithKline, LLC. ($8,377) |
| 2018 | $946.31 | 58 | GlaxoSmithKline, LLC. ($349.87) |
| 2017 | $1,341 | 64 | GlaxoSmithKline, LLC. ($470.65) |
All Payment Transactions
532 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $23.32 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $21.72 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $89.24 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Immunology | ||||||
| 08/08/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Pulmonology | ||||||
| 08/06/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,132 | 1,476 | $272,013 | $102,879 |
| 2022 | 9 | 1,072 | 1,393 | $229,274 | $94,004 |
| 2021 | 10 | 1,160 | 1,404 | $238,321 | $98,047 |
| 2020 | 10 | 1,313 | 1,664 | $275,575 | $97,575 |
Total Patients
4,677
Total Services
5,937
Medicare Billing
$392,506
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 449 | 570 | $57,570 | $33,238 | 57.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 223 | 344 | $52,288 | $27,653 | 52.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 29 | 30 | $57,000 | $12,621 | 22.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 23 | 24 | $48,000 | $10,807 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $19,505 | $9,300 | 47.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 195 | 295 | $20,945 | $4,951 | 23.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 39 | 39 | $4,095 | $1,521 | 37.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 39 | 39 | $6,240 | $1,440 | 23.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 39 | 39 | $4,290 | $1,026 | 23.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 13 | 13 | $2,080 | $322.40 | 15.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 441 | 547 | $55,247 | $32,361 | 58.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 245 | 354 | $53,891 | $29,886 | 55.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 24 | 25 | $47,500 | $11,044 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $13,160 | $6,252 | 47.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 13 | 13 | $26,000 | $5,857 | 22.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 196 | 301 | $21,371 | $5,395 | 25.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 33 | 33 | $3,465 | $1,277 | 36.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 32 | 32 | $5,120 | $1,146 | 22.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 32 | 32 | $3,520 | $784.99 | 22.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 470 | 566 | $57,166 | $33,161 | 58.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 271 | 352 | $53,504 | $31,249 | 58.4% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2021 | 19 | 20 | $40,000 | $9,057 | 22.6% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 20 | 20 | $38,000 | $8,537 | 22.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 63 | 63 | $14,805 | $6,655 | 45.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 188 | 251 | $17,821 | $4,691 | 26.3% |
About Dr. Daniel Smith, MD
Dr. Daniel Smith, MD is a Pulmonary Disease healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043209265.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Smith, MD has received a total of $21,948 in payments from pharmaceutical and medical device companies, with $1,425 received in 2024. These payments were reported across 532 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,500).
As a Medicare-enrolled provider, Smith has provided services to 4,677 Medicare beneficiaries, totaling 5,937 services with total Medicare billing of $392,506. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Chattanooga, TN
- Active Since 10/20/2005
- Last Updated 12/07/2016
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1043209265
Products in Payments
- TRELEGY ELLIPTA (Drug) $11,835
- XYWAV (Drug) $649.71
- Sunosi (Drug) $642.91
- Yupelri (Drug) $548.88
- Wakix (Drug) $517.32
- SUNOSI (Drug) $371.79
- BEVESPI AEROSPHERE (Drug) $348.84
- YUPELRI (Drug) $344.05
- BREZTRI (Drug) $335.97
- GLASSIA (Biological) $305.41
- Xyrem (Drug) $280.88
- ANORO (Drug) $261.52
- Prolastin-C Liquid (Biological) $256.77
- ANORO ELLIPTA (Drug) $226.55
- Neupro (Drug) $223.37
- DUPIXENT (Biological) $220.82
- BREO (Drug) $218.62
- STIOLTO RESPIMAT (Drug) $214.50
- QUVIVIQ (Drug) $200.80
- LUMRYZ (Drug) $169.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Chattanooga
Dr. Carlos Baleeiro, Md, MD
Pulmonary Disease — Payments: $316,465
Pulmonary Disease $316,465
Dr. Upasana Bardhan Chakraborty, M.d, M.D
Pulmonary Disease — Payments: $12,425
Pulmonary Disease $12,425
John Boldt, Md, MD
Pulmonary Disease — Payments: $9,443
Pulmonary Disease $9,443
Vincent Viscomi, Md, MD
Pulmonary Disease — Payments: $8,431
Pulmonary Disease $8,431
Dr. Harsha Shanthaveerappa, Md Fccp, MD FCCP
Pulmonary Disease — Payments: $5,313
Pulmonary Disease $5,313
Winfred Manda, Md, MD
Pulmonary Disease — Payments: $4,698
Pulmonary Disease $4,698